This Solicitation opportunity from Department Of Defense was posted on April 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ENROFLOXACIN TABLET
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Enrofloxacin tablets are a veterinary antibiotic product containing 68 mg per tablet at a 7% concentration, formulated for use in dogs and cats only, offering broad-spectrum antibacterial activity against both gram-negative and gram-positive bacteria. The product is packaged in bottles of 250 tablets per unit, with strict storage requirements mandating controlled room temperature conditions. All packaging and marking must comply with the latest edition of the Medical Marking Standard No. 1, and the item is subject to DLA packaging requirements and technical quality specifications referenced in the DLA Master List of Technical and Quality Requirements. This is classified as a TYPE I (CODE Q) item with a non-extendable shelf life of 36 months. The item is regulated by the FDA, and buyers must submit a referral through EBS to confirm regulatory compliance, including manufacturer details, part numbers, and product descriptions. The contract specifies a single unit of issue, one bottle containing 250 tablets, delivered FOB destination within 84 days, with no tolerance for quantity variance. Delivery is to APO 96260-5479 under the solicitation number SPE2DP-26-T-3047, with inspection and acceptance occurring at the destination point. The NSN is 6509014875834, and the item is procured under the NAICS code 325412 for pharmaceutical manufacturing. Primary contract oversight is managed by the Department of Defense’s Medical Supply Chain PHARM FSA, with Shairy M. Cartagena as the point of contact.
General Info
Agency
Contract Value
$283.86NAICS
Place of Performance
UNIT 15479, APO, AP, 96260-5479, USASet-Aside
Awardee
Award Issued Date
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
ENROFLOXACIN TABLETS
.
68 MG<(>,<)> 7% CONCENTRATION FOR VETERINARY USE IN DOGS <(>&<)> CATS
ONLY; PROVIDES ANTIBACTERIAL ACTIVITY AGAINST A BROAD SPECTRUM OF GRAM
NEGATIVE AND GRAM POSITIVE BACTERIA
.
UNIT OF ISSUE: BOTTLE (BT) OF 250EA (TABLETS)
.
STORE AT CONTROLLED ROOM TEMPERATURE
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
PATTERSON VETERINARY SUPPLY, INC. 3G5T7 P/N 07-895-0762 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 083184
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3047
SECTION B
PR: 7016500107 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016500107 0001 BT 1.000
NSN/MATERIAL:6509014875834
DELIVERY (IN DAYS):0084
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6509-01-487-5834 Quantity: 1 BT Purchase Request: 7016500107QTY: 1 Delivery: 84 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS